DEFINITIVE CONTRACT

UNIVERSITY OF CHICAGO - DEVELOPMENT OF VACCINES FOR INFLUENZA USING AN IMMUNO-MODULATOR ADJUVANT AND MULTI-PLATFORM APPROACH

PIID: 75N93023C00044
Effective Date: Sep 30, 2023End Date: Closes in 845 days
Award $
$7.3M
Vendor
UNIVERSITY OF CHICAGO
NAICS
541512

Key Details

Dollars Obligated
$7.3M
Awarding Sub-Agency
National Institutes of Health
NAICS Code
541512
Place of Performance
IL

Description

DEVELOPMENT OF VACCINES FOR INFLUENZA USING AN IMMUNO-MODULATOR ADJUVANT AND MULTI-PLATFORM APPROACH

Context & Analysis

Department of Health and Human Services obligated $7,281,050.38 to UNIVERSITY OF CHICAGO for development of vaccines for influenza using an immuno-modulator adjuvant and multi-platform approach. The award is classified under NAICS 541512 and issued as a definitive contract contract. Performance is located in IL. The contract is scheduled through Sep 29, 2028. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541512 — related awards are listed below.

Contractor Information

UEI: ZUE9HKT2CLC9
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related

NAICS Codes
541512